Evidence map›Paper›PMID 21459331›Full record

ArticleCell metabolism2011

AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure.

Susan B Gurley, Anne D M Riquier-Brison, Jurgen Schnermann, Matthew A Sparks, Andrew M Allen, Volker H Haase, John N Snouwaert, Thu H Le, Alicia A McDonough, Beverley H Koller and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 160 papers.

0numbers the graph read from it
0cells of the map it votes in
160citing papers in PubMed
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

160 citing papers in PubMed, 250 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Salt and chronic kidney disease.Nature reviews. Nephrology · 2026
    Review
  5. Vine Tea (International journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. A key role of ATAmerican journal of physiology. Renal physiology · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Deletion of ATAmerican journal of physiology. Renal physiology · 2024
    Article
  13. Review
  14. Angiotensinogen as a Therapeutic Target for Cardiovascular and Metabolic Diseases.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  15. Review
  16. New functions and roles of the NaPflugers Archiv : European journal of physiology · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article

100 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Susan B GurleyDivision of Nephrology, Department of Medicine, Duke University and Durham, VA Medical Centers, Durham, NC 27710, USA.
Anne D M Riquier-BrisonDepartment of Cell and Neurobiology, University of Southern California, Los Angeles, CA 90089, USA.
Jurgen SchnermannNational Institute of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Matthew A SparksDivision of Nephrology, Department of Medicine, Duke University and Durham, VA Medical Centers, Durham, NC 27710, USA.
Andrew M AllenDepartment of Physiology, University of Melbourne, Melbourne, Victoria 3010, Australia.
Volker H HaaseDivision of Nephrology and Hypertension, Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.
John N SnouwaertDepartment of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.
Thu H LeDivision of Nephrology, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
Alicia A McDonoughDepartment of Cell and Neurobiology, University of Southern California, Los Angeles, CA 90089, USA.
Beverley H KollerDepartment of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA.
Thomas M CoffmanDivision of Nephrology, Department of Medicine, Duke University and Durham, VA Medical Centers, Durham, NC 27710, USA; Cardiovascular and Metabolic Disorders Research Program, Duke-NUS Graduate Medical School, Singapore 169857. Electronic address: tcoffman@duke.edu.
Duke University · USUniversity of North Carolina at Chapel Hill · USUniversity of Southern California · USNational Institutes of Health · USThe University of Melbourne · AUUniversity of Virginia · USVanderbilt University · US

Funding

Sodium transporter regulation during hypertensionR01DK083785 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AURELIE EDWARDS, Alicia A. McDonough · 2011 to 2026
$5.8M
Molecular Mechanisms of Renal InjuryR01DK081646 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HAASE, VOLKER HANS · 2008 to 2021
$4.3M
Renal Function In Transgenic MiceZIADK043408 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI SCHNERMANN, JURGEN · 2009 to 2012
$3.7M
ANGIOTENSIN RECEPTOR GENES AND BLOOD PRESSURE REGULATIONR01HL056122 · NHLBI · DUKE UNIVERSITY · PI COFFMAN, THOMAS M · 1997 to 2010
$3.2M
Sodium-chloride co-transporter regulation in the kidneyR56DK083785 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MCDONOUGH, ALICIA A., YU, ALAN S · 2010 to 2010
$173k
NHLBI NIH HHS 2R01 HL056122NHLBI NIH HHS R01 HL056122NIDDK NIH HHS DK083785NIDDK NIH HHS R01 DK081646NIDDK NIH HHS R01 DK083785
6 · The paper itself

Abstract

Hypertension affects more than 1.5 billion people worldwide but the precise cause of elevated blood pressure (BP) cannot be determined in most affected individuals. Nonetheless, blockade of the renin-angiotensin system (RAS) lowers BP in the majority of patients with hypertension. Despite its apparent role in hypertension pathogenesis, the key cellular targets of the RAS that control BP have not been clearly identified. Here we demonstrate that RAS actions in the epithelium of the proximal tubule have a critical and nonredundant role in determining the level of BP. Abrogation of AT(1) angiotensin receptor signaling in the proximal tubule alone is sufficient to lower BP, despite intact vascular responses. Elimination of this pathway reduces proximal fluid reabsorption and alters expression of key sodium transporters, modifying pressure-natriuresis and providing substantial protection against hypertension. Thus, effectively targeting epithelial functions of the proximal tubule of the kidney should be a useful therapeutic strategy in hypertension.

Indexed as

AnimalsBlood PressureHypertensionKidney Tubules, ProximalMiceReceptor, Angiotensin, Type 1Renin-Angiotensin SystemSignal TransductionSodiumSodium-Hydrogen Exchanger 3Sodium-Hydrogen ExchangersSodium-Potassium-Chloride SymportersSolute Carrier Family 12, Member 1Receptor, Angiotensin, Type 1Slc12a1 protein, mouseSodiumSodium-Hydrogen Exchanger 3Sodium-Hydrogen ExchangersSodium-Potassium-Chloride SymportersSolute Carrier Family 12, Member 1

Identifiers

PMID21459331
PMCPMC3070917
OpenAlexW2058539932

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.